Phase 3Completed

Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device

Sponsor
Fenwal, Inc. (Industry)
Enrollment
37 enrolled
Conditions
Autoimmune Diseases; Renal Disorders; Hematologic Disorders; Oncologic Disorders
Interventions
Therapeutic plasma exchange
Ages
adults, older adults
Registry
NCT01210716

Full record on ClinicalTrials.gov

From the registry

This study will evaluate the use of the AMICUS device in patients where Therapeutic Plasma Exchange (TPE) is prescribed by their physicians.

Primary outcomes

  • Percent Efficiency of Plasma Removal During the Therapeutic Plasma Exchange Procedure

History

  1. Results first posted

  2. Last registry update

  3. Primary completion

  4. Registered

  5. Started